Published in FEBS Lett on September 19, 1983
Defective inflammatory response in interleukin 6-deficient mice. J Exp Med (1994) 2.92
The acute-phase response of cultured rat hepatocytes. System characterization and the effect of human cytokines. Biochem J (1984) 1.78
Identification of the promoter sequences involved in the interleukin-6 dependent expression of the rat alpha 2-macroglobulin gene. Nucleic Acids Res (1989) 1.17
Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunology (1987) 1.15
alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers. Am J Pathol (2004) 0.96
Regulation of rabbit acute phase protein biosynthesis by monokines. Biochem J (1988) 0.86
The acute-phase protein response in parasite infection. Nippostrongylus brasiliensis and Trichinella spiralis in the rat. Immunology (1990) 0.83
A new negatively regulated acute-phase phosphoprotein synthesized by rat hepatocytes. Biochem J (1985) 0.80
Regulation of plasma acute-phase protein and albumin levels in the liver of scalded rats. Biochem J (1989) 0.79
Acute-phase-response induction in rat hepatocytes co-cultured with rat liver epithelial cells. Biochem J (1990) 0.78
Alpha 2-macroglobulin gene expression during rat development studied by in situ hybridization. EMBO J (1986) 0.77
Studies of translatable mRNA for rabbit C-reactive protein. Biochem J (1985) 0.77
The effects of 17 alpha-ethynyloestradiol and of acute inflammation on the plasma concentration of rat alpha 1-acid glycoprotein and on the induction of its hepatic mRNA. Biochem J (1985) 0.77
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
Interleukin-6 and the acute phase response. Biochem J (1990) 7.97
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem (1995) 5.36
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology (1998) 3.82
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology (2000) 3.46
Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol (1993) 3.37
Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology (1990) 3.27
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology (1992) 3.17
Rational design of faster associating and tighter binding protein complexes. Nat Struct Biol (2000) 3.03
Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J (1994) 2.83
Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet (1995) 2.81
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology (2002) 2.80
Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett (1989) 2.79
Control of proteolysis. Annu Rev Biochem (1980) 2.67
Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell (1989) 2.65
The modular architecture of protein-protein binding interfaces. Proc Natl Acad Sci U S A (2004) 2.48
Characterization of the relA1 mutation and a comparison of relA1 with new relA null alleles in Escherichia coli. J Biol Chem (1989) 2.46
The nucleotide sequence and characterization of the relA gene of Escherichia coli. J Biol Chem (1988) 2.45
Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett (1988) 2.39
Protein-protein recognition: crystal structural analysis of a barnase-barstar complex at 2.0-A resolution. Biochemistry (1994) 2.38
Chemolithoautotrophic metabolism of anaerobic extremely thermophilic archaebacteria. Nature (1983) 2.38
Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res (2000) 2.31
Cytokines in inflammatory bowel disease. World J Surg (1998) 2.30
The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol (1994) 2.26
Analysis of heart rate variability demonstrates effects of development on vagal modulation of heart rate in healthy children. J Pediatr (1997) 2.24
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol (1997) 2.20
SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem (2000) 2.14
Electrostatic enhancement of diffusion-controlled protein-protein association: comparison of theory and experiment on barnase and barstar. J Mol Biol (1998) 2.13
Simplified northern blot hybridization using 5% sodium dodecyl sulfate. Biotechniques (1990) 2.07
Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett (1987) 2.04
The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol (1993) 2.01
Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol (1999) 1.97
Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol (1988) 1.95
Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol (1992) 1.94
The receptor of the type I interferon family. Curr Top Microbiol Immunol (2007) 1.94
Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis. Arch Dermatol (1991) 1.88
Rat transthyretin (prealbumin). Molecular cloning, nucleotide sequence, and gene expression in liver and brain. J Biol Chem (1985) 1.87
Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy (1998) 1.83
Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood (1988) 1.76
Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins. Eur J Immunol (1988) 1.76
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut (1996) 1.73
Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol (1996) 1.72
Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest (2001) 1.71
Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease. Eur J Clin Invest (1999) 1.71
The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol Cell Biol (1994) 1.70
Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem (1988) 1.69
Circular dichroism of ribonucleoprotein complexes from rat liver nuclei. Biochem Biophys Res Commun (1977) 1.69
Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart (2003) 1.69
Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol (1998) 1.68
The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol Cell Biol (1994) 1.67
Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature (1988) 1.67
Acute-phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin 6 response element of the rat alpha 2-macroglobulin gene. Proc Natl Acad Sci U S A (1990) 1.66
Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid. Endoscopy (1998) 1.62
Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology (1991) 1.61
A case study in ontology library construction. Artif Intell Med (1995) 1.60
A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology (1990) 1.60
Thermodynamics of the interaction of barnase and barstar: changes in free energy versus changes in enthalpy on mutation. J Mol Biol (1997) 1.59
Evaluation of direct and cooperative contributions towards the strength of buried hydrogen bonds and salt bridges. J Mol Biol (2000) 1.59
Expression of the genes coding for the Escherichia coli integration host factor are controlled by growth phase, rpoS, ppGpp and by autoregulation. Mol Microbiol (1994) 1.56
Transcriptional regulation of plasma protein synthesis during inflammation. J Biol Chem (1986) 1.55
Predicting the rate enhancement of protein complex formation from the electrostatic energy of interaction. J Mol Biol (1999) 1.53
Immunopathologic study of lichenoid skin diseases: correlation between HLA-DR-positive keratinocytes or Langerhans cells and epidermotropic T cells. J Am Acad Dermatol (1988) 1.51
Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol Cell Biol (1997) 1.51
The proption of the incorporation of leucine into albumin to that into totaprotein in rat liver and hepatoma Morris 5123 TC. Eur J Biochem (1969) 1.50
Psoriasis and lichen planus: coexistence in a single patient. Are both diseases mutually exclusive? Dermatologica (1989) 1.49
Differential expression of lymphocyte function-associated antigen 1 (LFA-1) on epidermotropic and non-epidermotropic T-cell clones. J Invest Dermatol (1989) 1.48
Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res (1994) 1.47
A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor. J Biol Chem (1996) 1.47
LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett (1999) 1.46
STAT3 is constitutively activated in Hodgkin cell lines. Blood (2001) 1.42
The acute phase response of plasma protein synthesis during experimental inflammation. J Biol Chem (1982) 1.41
OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg (1991) 1.40
[Obesity surgery: the refusal rate of health care cost reimbursement despite expert opinion]. Dtsch Med Wochenschr (2006) 1.39
Sequence of rat liver alpha 2-macroglobulin and acute phase control of its messenger RNA. J Biol Chem (1987) 1.38
Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int (1990) 1.36
Effect of swainsonine on the processing of the asparagine-linked carbohydrate chains of alpha 1-antitrypsin in rat hepatocytes. Evidence for the formation of hybrid oligosaccharides. J Biol Chem (1983) 1.35
Binding hot spots in the TEM1-BLIP interface in light of its modular architecture. J Mol Biol (2006) 1.34
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol (2000) 1.33
New insights into the mechanism of protein-protein association. Proteins (2001) 1.32
Hypertension-induced end-organ damage : A new transgenic approach to an old problem. Hypertension (1999) 1.32